DocGo (NASDAQ:DCGO - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They presently have a $3.00 price target on the stock. Needham & Company LLC's price target would indicate a potential upside of 322.48% from the stock's current price.
A number of other research firms have also recently issued reports on DCGO. Weiss Ratings restated a "sell (e+)" rating on shares of DocGo in a report on Thursday, June 18th. Cantor Fitzgerald reiterated an "overweight" rating on shares of DocGo in a research report on Monday, May 11th. Finally, Wall Street Zen raised shares of DocGo from a "sell" rating to a "hold" rating in a research note on Saturday, May 16th. Three investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $2.38.
Read Our Latest Research Report on DocGo
DocGo Stock Performance
Shares of DCGO stock opened at $0.71 on Tuesday. The company has a market cap of $70.12 million, a P/E ratio of -0.37 and a beta of 0.99. The stock has a 50 day simple moving average of $0.60 and a two-hundred day simple moving average of $0.64. DocGo has a fifty-two week low of $0.45 and a fifty-two week high of $1.73.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Neuberger Berman Group LLC bought a new stake in shares of DocGo during the fourth quarter valued at approximately $29,000. Cerity Partners LLC bought a new position in shares of DocGo in the 2nd quarter worth $37,000. Public Employees Retirement System of Ohio bought a new position in shares of DocGo in the 4th quarter worth $40,000. Engineers Gate Manager LP bought a new position in shares of DocGo in the 2nd quarter worth $52,000. Finally, Diversify Advisory Services LLC acquired a new stake in DocGo in the 2nd quarter valued at $53,000. Institutional investors own 56.44% of the company's stock.
DocGo Company Profile
(
Get Free Report)
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.